Stockreport

ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue

Adicet Bio, Inc.  (ACET) 
Last adicet bio, inc. earnings: 5/3 05:00 pm Check Earnings Report
US:NASDAQ Investor Relations: aceto.com/ir/index.html
PDF -Results highlight ADI-001's potential as a best-in-class allogeneic cell therapy for autoimmune disease--Webcast featuring Dr. Blake Aftab with accompanying presentatio [Read more]